Conference Reports

ID Week 2020 Virtual Conference

21 October 2020 - 25 October 2020

American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU 2020)

San Francisco, California, US

13 February 2020 - 15 February 2020

17th Urological Association of Asia Congress (UAA) 2019

07 August 2019 - 10 August 2019

Uro-Oncology Asia 2019

19 January 2019 - 20 January 2019

European Association of Urology (EAU) 2018 Congress

Copenhagen

16 March 2018 - 19 March 2018

2018 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU 2018)

San Francisco, California

08 February 2018 - 10 February 2018

Hong Kong Society of Uro-Oncology Annual Scientific Meeting 2018

Hong Kong

20 January 2018 - 20 January 2018

Spotlight on multidrug-resistant gram-negative infections: New developments for an old problem

Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021

Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.

Standing good for heart health

Jairia Dela Cruz, 5 days ago

Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.

Does thyroid hormone therapy provide survival benefits in subclinical hypothyroidism?

5 days ago

Use of thyroid hormone therapy does not seem to protect older adults with subclinical hypothyroidism against mortality, but it appears to confer survival benefits to those aged <65 years, results of a study have shown.